Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001794362-25-000005

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tressler Nick B. Chief Financial Officer 2025-12-01 Grant or award · Common Stock (Right to Buy) +150,000 150,000 D
Loading xslF345X05/form4-12042025_111200.xml…